1.
Han X, Wu Y, Zhuang Y, Zhang J. Dexmedetomidine reduces dextran sulfate sodium (DSS)-induced NCM460 cell inflammation and barrier damage by inhibiting RhoA/ROCK signaling pathway. Allergol Immunopathol [Internet]. 2022 May 1 [cited 2026 Jun. 14];50(3):85-92. Available from: https://all-imm.com/index.php/aei/article/view/569